Our Remarkable Journey
We've consistently demonstrated our commitment to excellence by navigating through various audits conducted by regulatory authorities and customers globally, solidifying our growth and reputation in the field.
Our journey in the pharmaceutical industry has been defined by a succession of pivotal achievements.
Alkaloids Private Limited was established.
Alkaloids Private Limited developed its first Scopolamine/Hyoscine Salt.
Alkaloids first Block in the manufacturing facility, was inaugurated.
Alkaloids Private Limited received its first Certificate of Suitability (CEP) for Hyoscine Butylbromide.
Block II, expanding Alkaloids manufacturing capacity, was inaugurated.
Alkaloids Private Limited attained its first KMFDS accreditation.
Alkaloids Private Limited completed its first USFDA audit, resulting in facility acceptance.
Block III, Alkaloids largest manufacturing facility to date, wass inaugurated. Alkaloids also acquired its first piece of farmland in Australia for biomass.
Alkaloids Private Limited established its Process Development Lab.
Alkaloids Private Limited successfully cleared its first TGA Audit
Alkaloids Private Limited completed its first EDQM audit.
The Potent Molecule Handling Block was established in Block III.
What We Have Accomplished
Alkaloids milestones underscore its commitment to quality and compliance, as well as its unwavering dedication to pushing the boundaries of pharmaceutical innovation. Each achievement is a testament to the company's enduring pursuit of excellence.
Years in business
Get To Know More
About our products, send us a query or
download our catalog.